Case of the Month #57 A haematology patient with shock

Published 09/10/2025

References

  1. Chimeric antigen receptor T-cell therapy in adults: management of toxicities and implications for critical care Haseeb, F. et al. BJA Education, Volume 22, Issue 9, 330 - 333  
  2. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Schuster, Stephen J et al. The New England journal of medicine vol. 380,1 (2019): 45-56. doi:10.1056/NEJMoa1804980 
  3. Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study. Azoulay, ÉlieZafrani, Lara et al. The Lancet Haematology, Volume 8, Issue 5, e355 - e364  
  4. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Morris, E.C., Neelapu, S.S., Giavridis, T. et al. Nat Rev Immunol 22, 85–96 (2022). https://doi.org/10.1038/s41577-021-00547-6 
  5. CAR-T cell therapy recipient in the ICU. Farkas, J. Internet Book of Critical Care (2025) viewed at https://emcrit.org/ibcc/cart/#initial_evaluation on 21/6/25 
  6. A Primer on Chimeric Antigen Receptor T-cell Therapy-related Toxicities for the Intensivist. Ong, Shin Yeu, and John H Baird.  Journal of intensive care medicine vol. 39,10 (2024): 929-938. doi:10.1177/08850666231205264 
  7. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. Daniel W. Lee, Bianca D. Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle, Jennifer N. Brudno, Marcela V. Maus, Jae H. Park, Elena Mead, Steven Pavletic, William Y. Go, Lamis Eldjerou, Rebecca A. Gardner, Noelle Frey, Kevin J. Curran, Karl Peggs, Marcelo Pasquini, John F. DiPersio, Marcel R.M. van den Brink, Krishna V. Komanduri, Stephan A. Grupp, Sattva S. Neelapu. Biology of Blood and Marrow Transplantation, Volume 25, Issue 4,2019,Pages 625-638,ISSN 1083-8791,https://doi.org/10.1016/j.bbmt.2018.12.758. 
  8. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Yakoub-Agha I, Chabannon C, Bader P, Basak GW, Bonig H, Ciceri F, Corbacioglu S, Duarte RF, Einsele H, Hudecek M, Kersten MJ, Köhl U, Kuball J, Mielke S, Mohty M, Murray J, Nagler A, Robinson S, Saccardi R, Sanchez-Guijo F, Snowden JA, Srour M, Styczynski J, Urbano-Ispizua A, Hayden PJ, Kröger N. Haematologica. 2020 Jan 31;105(2):297-316. doi: 10.3324/haematol.2019.229781.  
  9. Management of CAR-T cell-related encephalopathy syndrome in adult and pediatric patients: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC). Cornillon, J., Hadhoum, N., Roth-Guepin, G., Quessar, A., Platon, L., Ouachee-Chardin, M., ... & Yakoub-Agha, I. (2019).  Bulletin du cancer, 107(1S), S12-S17.